Everolimus: an update on the mechanism of action, pharmacokinetics and recent clinical trials.
Sánchez-Fructuoso, Ana I
Everolimus: an update on the mechanism of action, pharmacokinetics and recent clinical trials. [electronic resource] - Expert opinion on drug metabolism & toxicology Jun 2008 - 807-19 p. digital
Publication Type: Journal Article; Review; Systematic Review
1742-5255
10.1517/17425255.4.6.807 doi
Antineoplastic Agents--therapeutic use
Clinical Trials as Topic
Cytomegalovirus Infections--immunology
Drug Monitoring
Everolimus
Graft Rejection--immunology
Graft Survival--drug effects
Heart Transplantation
Humans
Immunosuppressive Agents--adverse effects
Kidney Transplantation
Neoplasms--drug therapy
Organ Transplantation--adverse effects
Sirolimus--adverse effects
Treatment Outcome
Everolimus: an update on the mechanism of action, pharmacokinetics and recent clinical trials. [electronic resource] - Expert opinion on drug metabolism & toxicology Jun 2008 - 807-19 p. digital
Publication Type: Journal Article; Review; Systematic Review
1742-5255
10.1517/17425255.4.6.807 doi
Antineoplastic Agents--therapeutic use
Clinical Trials as Topic
Cytomegalovirus Infections--immunology
Drug Monitoring
Everolimus
Graft Rejection--immunology
Graft Survival--drug effects
Heart Transplantation
Humans
Immunosuppressive Agents--adverse effects
Kidney Transplantation
Neoplasms--drug therapy
Organ Transplantation--adverse effects
Sirolimus--adverse effects
Treatment Outcome